Gutmann et al. [181] conducted a prospective study to evaluate PTX3 serum levels in 123 hospitalized COVID-19, 25 non-COVID-19 ICU sepsis, and 30 healthy control patients. This evidence concerns the gene PTX3 and Sepsis.